U.S. Bankruptcy Judge Robert Drain of the Bankruptcy Court for the Southern District of New York on Wednesday said he will approve the $4.5 billion settlement for the bankruptcy of Purdue Pharma, the company that produced and marketed OxyContin, after two tweaks are made to the proposed settlement.
![Southern District Bankruptcy Court Judge Robert D. Drain](https://images.law.com/contrib/content/uploads/sites/389/2021/09/Robert-D.-Drain-Southern-District-Bankruptcy-Court-Judge..041408-Vert-202109011707-186x300.jpg)
The U.S. Department of Justice plans to appeal, and will file a motion for a stay pending appeal soon, Benjamin Higgins of the U.S. Trustee’s Office said in court.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]